Pharmaceuticals

Cell and Gene Therapy Market Forecast 2026–2035 Highlighting Industry Insights

March 29, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The Cell and Gene Therapy Market Over The Period 2026–2030?

The cell and gene therapy market size has experienced rapid growth in recent years. It is projected to increase from $21.33 billion in 2025 to $26.21 billion in 2026, achieving a compound annual growth rate (CAGR) of 22.9%. Historically, this growth can be attributed to factors such as the limited availability of cell and gene therapies, the dependence on conventional treatment modalities, the high cost of early-generation therapies, the increasing incidence of oncology and neurological disorders, and the scarcity of specialized treatment centers.

The cell and gene therapy market is anticipated to experience substantial expansion over the upcoming years. Its size is projected to reach $60.58 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 23.3%. This growth during the projected timeframe is largely driven by factors such as the advancement of sophisticated CAR-T and genome editing treatments, the broadening of clinical trials and research initiatives, a greater embrace of personalized medical approaches, augmented government backing and financing for therapies addressing rare diseases, and the incorporation of digital tools for overseeing treatment and managing patients. Key trends expected within this period encompass a growing acceptance of CAR-T and stem cell therapies, a surge in investment directed towards gene therapy for cancer and uncommon conditions, an increase in customized and focused cell-based treatments, the proliferation of hospitals and outpatient surgical centers providing cutting-edge therapies, and the incorporation of genome editing and viral vector-based techniques into routine clinical applications.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3472&type=smp

What Underlying Factors Are Accelerating The Growth Of The Cell and Gene Therapy Market?

The increasing volume of ongoing clinical trials is anticipated to propel the expansion of the cell and gene therapy market. These trials are research studies involving human participants, designed to assess the safety and efficacy of novel medical treatments, interventions, or diagnostic methods. They play a vital role in the development and advancement of cell and gene therapy, providing a secure and regulated setting to evaluate new therapies and collect data on their safety and effectiveness. For instance, the Association of the British Pharmaceutical Industry (ABPI), a UK-based organization, reported in December 2024 that the number of pharmaceutical industry trials launched in the UK increased for the second consecutive year, rising from 411 in 2022 to 426 in 2023. Consequently, the expanding number of ongoing clinical trials is driving the growth of the cell and gene therapy market.

How Is The Cell and Gene Therapy Market Divided Into Its Major Segments?

The cell and gene therapy market covered in this report is segmented –

1) By Product: Cell Therapy, Gene Therapy

2) By Application: Oncology, Neurological Disorders, Other Applications

3) By End User: Hospitals, Ambulatory Surgical Centers, Cancer Care Centers, Wound Care Centers, Other End-Users

Subsegments:

1) By Cell Therapy: Autologous Cell Therapy, Allogeneic Cell Therapy, Stem Cell Therapy, CAR-T Cell Therapy

2) By Gene Therapy: Viral Vector-Based Gene Therapy, Non-Viral Vector-Based Gene Therapy, Genome Editing Technologies, Antisense Oligonucleotide Therapy

How Are Trends Transforming The Cell and Gene Therapy Market Landscape?

Leading companies operating within the cell and gene therapy market are intensifying their efforts to introduce agnostic systems, aiming to secure a competitive advantage. Agnostic systems are defined as those capable of integrating with a diverse range of cell and gene therapy (CGT) software platforms, as well as biopharmaceutical or provider-facing platforms. Illustratively, in April 2023, AmerisourceBergen, a US-based healthcare company, launched the Cell and Gene Therapy Integration Hub. This new platform-agnostic system is designed to enhance connectivity throughout the cell and gene therapy (CGT) treatment journey, ultimately fostering a superior patient and provider experience. The hub is powered by the company’s customer relationship management system and is intended to accelerate the benefits investigation process, provide a real-time perspective on therapy development and transportation status, and aid in coordinating patient support.

Who Are The Prominent Organizations Shaping The Cell and Gene Therapy Market?

Major companies operating in the cell and gene therapy market are Biogen Inc., Novartis AG, Gilead Sciences, Ionis Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., ArrowHead Pharmaceuticals Inc., Spark Therapeutics, Bluebird Bio Inc., RegenexBio, Mesoblast Limited, Stempeutics Research Pvt. Ltd., EdiGene Inc., Takara Bio, Oxford Biomedica plc, Merck, GenScript, Cellular Biomedicine Group, inStem, Bristol-Myers Squibb, Amgen, Pfizer, Kite Pharma, Freeline Therapeutics, PsiOxus Therapeutics, Herantis Pharma Plc, AstraZeneca

Read the full cell and gene therapy market report here:

https://www.thebusinessresearchcompany.com/report/cell-and-genes-therapy-global-market-report

Which Region Is Projected To Dominate The Cell and Gene Therapy Market During The Forecast Period?

North America was the largest region in the cell and gene therapy market in 2025. The regions covered in the cell and gene therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Cell and Gene Therapy Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=3472&type=smp

Browse Through More Reports Similar to the Global Cell and Gene Therapy Market 2026, By The Business Research Company

Cancer Biologics Market Report 2026

https://www.thebusinessresearchcompany.com/report/cancer-biologics-global-market-report

Nucleic Acid Based Gene Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/nucleic-acid-based-gene-therapy-global-market-report

Genes Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795